VC firm
MPM BioImpact
Also known as MPM, MPM Bio 2014 NVS Strategic, MPM Bio 2014 NVS Strategic Fund, L.P., MPM BIOVENTURES, MPM BioVentures 2014, MPM BioVentures 2014, L.P., MPM BIOVENTURES 2018, MPM BIOVENTURES 2018 (B), L.P.
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- CAMBRIDGE, MA, United States
- Founded
- 1997
- Assets under management
- $3BStated by firm, as of 2026-09-17Source (opens in a new tab)
- Latest fund size
- $483MForm ADV gross asset value, as of 2017Source (opens in a new tab)
- Funds
- 24
- Legal name
- MPM BioImpact LLC
- mpmbioimpact.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Team page (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
We are a world-leading biotechnology investment firm with three decades of experience building and investing in innovative companies across all stages of development seeking to deliver transformative therapies to patients.
Investment approach
- Thesis
- We invest in private and public companies across the drug development process with the goal of transforming scientific breakthroughs into life saving medicines.Source (opens in a new tab)
- Investing status notes
- We invest in private and public companies across the drug development process with the goal of transforming scientific breakthroughs into life saving medicines.
Funds
- MPM BioImpact Innovations Equities Master, LP
- $131MVintage 2024, Open-ended, SEC amount sold
- MPM BioImpact Innovations Equities Fund, LTD.
- $25.4MVintage 2024, Open-ended, SEC amount sold
- MPM BIOVENTURES 2018 (B), L.P.
- Vintage 2018Main fund
- MPM ONCOLOGY INNOVATIONS FUND LP
- $98.9MVintage 2017, Main fund, SEC amount sold
- MPM BIOVENTURES 2018, L.P.
- Vintage 2017Main fund
- MPM BioVentures 2014, L.P.
- $347MVintage 2014, Main fund, SEC amount sold
- MPM Bio 2014 NVS Strategic Fund, L.P.
- $22.5MVintage 2014, SPV, SEC amount sold
- MPM BIOVENTURES V, L.P.
- $140MVintage 2009, Main fund, SEC amount sold
- MPM BIOVENTURES IV-QP, L.P.
- Main fund
- MPM BIOVENTURES 2014 (B), L.P.
- Main fund
- MPM BIOIMPACT INNOVATIONS EQUITIES MASTER, LP
- Main fund
- MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG
- Main fund
- More funds
- 12 more recorded
SEC registration
- Registered adviser
- MPM ASSET MANAGEMENT LLC
- CRD number
- 148467 (opens in a new tab)
- SEC file number
- 801-106989
- Registration
- SEC registered
- Regulatory AUM
- $3.6Bas of 2026-04-28
- Private funds reported
- 14
- Principal office
- BOSTON, MA, United States
- SEC CIK
- 1482716, 1609492, 1609494
Loading relationship preview